Abstract:Prion diseases are a group of rare and fatal neurodegenerative diseases caused by the cellular prion protein, PrP , misfolding into the infectious form, PrP , which forms aggregates in the brain. This leads to activation of glial cells, neuroinflammation, and irreversible neuronal loss, however, the role of glial cells in prion disease pathogenesis and neurotoxicity is poorly understood. Microglia can phagocytose PrP , leading to the release of inflammatory signaling molecules, which subsequently induce astrocyte reactivity. Animal models show highly upregulated inflammatory molecules that are a product of the Nuclear Factor-kappa B (NF-κB) signaling pathway, suggesting that this is a key regulator of inflammation in the prion-infected brain. The activation of the IκB kinase complex (IKK) by cellular stress signals is critical for NF-κB-induced transcription of a variety of genes, including pro-inflammatory cytokines and chemokines, and regulators of protein homeostasis and cell survival. However, the contribution of microglial IKK and NF-κB signaling in the prion-infected brain has not been evaluated. Here, we characterize a primary mixed glial cell model containing wild-type (WT) astrocytes and IKK knock-out (KO) microglia. We show that, when exposed to prion-infected brain homogenates, NF-κB-associated genes are significantly downregulated in mixed glial cultures containing IKK KO microglia. Mice with IKK KO microglia show rapid disease progression when intracranially infected with prions, including an increase in microglia and reactive astrocytes, and accelerated loss of hippocampal neurons and associated behavioral deficits. These animals display clinical signs of prion disease early and have a 22% shorter life expectancy compared to infected wild-type mice. Intriguingly, PrP accumulation was significantly lower in the brains of infected animals with IKK KO microglia compared to age-matched controls, suggesting that accelerated disease is independent of PrP accumulation, highlighting a glial-specific pathology. Conversely, primary mixed glia with IKK KO microglia have significantly more PrP accumulation when exposed to infected brain homogenates. Together, these findings present a critical role in NF-κB signaling from microglia in host protection suggesting that microglial IKK may be involved in sufficient clearance of prions.

NF-κB Activated in PrP106-126-induced Neurotoxicity in Mouse Neuroblastoma Cells N2a

P75ntr Activation of NF-κB is Involved in PrP106-126-induced Apoptosis in Mouse Neuroblastoma Cells

Altered Expression of Neurotrophin Receptor P75 NTR in PrP106-126-induced Neurotoxicity of N2a Cells

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Prion Peptide PrP106-126 Induces Inducible Nitric Oxide Synthase and Proinflammatory Cytokine Gene Expression Through the Activation of NF-κB in Macrophage Cells.

Neurotoxic PrP106-126 Fragmentinduces Neuropathological Changes in Primary Cortical Neurons

Reduction of NF-κB (p65) in Scrapie-Infected Cultured Cells and in the Brains of Scrapie-Infected Rodents.

The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation

Effects of Overexpression of Nurr1 on Apoptosis of SK-N-SH Cells Induced by Neurotoxin 6-OHDA

PrP 106-126 Altered PrP Mrna Gene Expression in Mouse Microglia BV-2 Cells

Induction of Macrophage Migration by Neurotoxic Prion Protein Fragment

Removal of the Glycosylation of Prion, Protein Provokes Apoptosis in Sf126

Activation of Innate Immunity and Autophagy in Brain Tissues with Prion Disease and Degradation of Abnormal PrPs in Cells — China’s Studies

Alteration of NF-κB(p65) in Brain Tissue of Scrapie-139A Infected Mice

The Expression of IL-1β, TNF-α Induced by PrP106-126 in Microglia.

Altered Expression of the Prion Gene in Rat Astrocyte and Neuron Cultures Treated with Prion Peptide 106–126

Cytosolic prion protein induces apoptosis in human neuronal cell SH-SY5Y via mitochondrial disruption pathway.

The Impact of PrP106-126 on Prion Gene Expression of Cultured Neurons

Microglia-specific NF-κB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss

Antibody-Mediated Inhibition of Integrin Α5β1 Blocks Neurotoxic Prion Peptide PrP106–126-Induced Activation of BV2 Microglia

In Vitro Effect of Prion Peptide Prp 106-126 on Mouse Macrophages: Possible Role of Macrophages in Transport and Proliferation for Prion Protein